Food. Science. Momentum.In the emerging world of applied science, Whitewave Food (NYSE: WWAV), a spinoff from Dean Foods is prototypical of an emerging sector, that of applied science without the emphasis on electronic products such as phones and PCs. The company harnesses the power of nature with its focus on… Read More
Dr. Joe Duarte is Chief Investment Strategist and Editor of Profit Catalyst Alert and Weekly Cash Machine. He has been a professional investor and independent analyst since 1990. He is a former Registered Investment Advisor and author of the Bestselling "Options Trading for Dummies," now in its 4th edition and several other books including "Market Timing for Dummies" and "Successful Biotech Investing". Although Joe's favorite areas of the market are technology and healthcare, he is a versatile investor who enjoys finding that hidden gem stock before the crowd, no matter what the sector. He is an original CNBC Market Maven, and is visible regularly on Stockcharts.TV. He has published articles on Marketwatch.com and has been widely quoted in the major media including The Wall Street Journal and Barron’s magazine.
Analyst Articles
Food. Science. Momentum.In the emerging world of applied science, Whitewave Food (NYSE: WWAV), a spinoff from Dean Foods is prototypical of an emerging sector, that of applied science without the emphasis on electronic products such as phones and PCs. The company harnesses the power of nature with its focus on… Read More
Our foray into UBIO, the leveraged long biotech ETF, got a rough start. But those investors who have owned BIS, the inverse leveraged biotech ETF, especially simultaneously with UBIO have fared better overall since BIS shares have risen during the period in which UBIO has fallen. We still think that biotech… Read More
Our foray into UBIO, the leveraged long biotech ETF, got a rough start. But those investors who have owned BIS, the inverse leveraged biotech ETF, especially simultaneously with UBIO have fared better overall since BIS shares have risen during the period in which UBIO has fallen. We still think that biotech… Read More
Buy ProShares UltraPro Nasdaq Biotech ETF (UBIO) up to $27, with a stop loss at $23. Read More
Buy ProShares UltraPro Nasdaq Biotech ETF (UBIO) up to $27, with a stop loss at $23. Read More
Medidata (MDSO), crunches big data for health care companies at the research level. It not only has apps that help organize and study the research starting from the project stage to the clinical trial stage, but it also has an app that allows patient input… Read More
Medidata (MDSO), crunches big data for health care companies at the research level. It not only has apps that help organize and study the research starting from the project stage to the clinical trial stage, but it also has an app that allows patient input… Read More
- February 16, 2016
-
Download Issue
The main questions for biotech investors are whether there is a correlation between the price of oil and if there is such a correlation, what is it telling us at the current period and the potential for the price action in the biotech sector? Read More
The main questions for biotech investors are whether there is a correlation between the price of oil and if there is such a correlation, what is it telling us at the current period and the potential for the price action in the biotech sector? Read More